Vitamin D Levels and Lipid Response to Atorvastatin

Adequate vitamin D levels are necessary for good vascular health. 1,25-dihydroxycholecalciferol activates CYP3A4, an enzyme of the cytochrome P450 system, which metabolizes atorvastatin to its main metabolites. The objective of this study was to evaluate the response of cholesterol and triglycerides...

Full description

Saved in:
Bibliographic Details
Main Authors: José Luis Pérez-Castrillón, Laura Abad Manteca, Gemma Vega, Javier del Pino Montes, Daniel de Luis, Antonio Dueňas Laita
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2010/320721
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850174222435876864
author José Luis Pérez-Castrillón
Laura Abad Manteca
Gemma Vega
Javier del Pino Montes
Daniel de Luis
Antonio Dueňas Laita
author_facet José Luis Pérez-Castrillón
Laura Abad Manteca
Gemma Vega
Javier del Pino Montes
Daniel de Luis
Antonio Dueňas Laita
author_sort José Luis Pérez-Castrillón
collection DOAJ
description Adequate vitamin D levels are necessary for good vascular health. 1,25-dihydroxycholecalciferol activates CYP3A4, an enzyme of the cytochrome P450 system, which metabolizes atorvastatin to its main metabolites. The objective of this study was to evaluate the response of cholesterol and triglycerides to atorvastatin according to vitamin D levels. Sixty-three patients with acute myocardial infarction treated with low and high doses of atorvastatin were included. Levels of total cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol were measured at baseline and at 12 months of follow-up. Baseline levels of 25-hydroxyvitamin D (25-OHD) were classified as deficient (<30 nmol/L), insufficient (30–50 nmol/L), and normal (>50 nmol/L). In patients with 25-OHD <30 nmol/L, there were no significant changes in levels of total cholesterol (173±47 mg/dL versus 164±51 mg/dL), triglycerides (151±49 mg/dL versus 177±94 mg/dL), and LDL cholesterol (111±48 mg/dL versus 92 45± mg/dL); whereas patients with insufficient (30–50 nmol/L) and normal vitamin D (>50 nmol/L) had a good response to atorvastatin. We suggest that vitamin D concentrations >30 nmol/L may be required for atorvastatin to reduce lipid levels in patients with acute myocardial infarction.
format Article
id doaj-art-c9d28865bc0d4883b92480eb7042e8ec
institution OA Journals
issn 1687-8337
1687-8345
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-c9d28865bc0d4883b92480eb7042e8ec2025-08-20T02:19:42ZengWileyInternational Journal of Endocrinology1687-83371687-83452010-01-01201010.1155/2010/320721320721Vitamin D Levels and Lipid Response to AtorvastatinJosé Luis Pérez-Castrillón0Laura Abad Manteca1Gemma Vega2Javier del Pino Montes3Daniel de Luis4Antonio Dueňas Laita5Department Internal Medicine, Rio Hortega Universitary Hospital, C/ Dulzaina 2, University of Valladolid, 47012 Valladolid, SpainDepartment Internal Medicine, Rio Hortega Universitary Hospital, C/ Dulzaina 2, University of Valladolid, 47012 Valladolid, SpainDepartment Internal Medicine, Rio Hortega Universitary Hospital, C/ Dulzaina 2, University of Valladolid, 47012 Valladolid, SpainRETICEF, SpainDepartment Internal Medicine, Rio Hortega Universitary Hospital, C/ Dulzaina 2, University of Valladolid, 47012 Valladolid, SpainDepartment Internal Medicine, Rio Hortega Universitary Hospital, C/ Dulzaina 2, University of Valladolid, 47012 Valladolid, SpainAdequate vitamin D levels are necessary for good vascular health. 1,25-dihydroxycholecalciferol activates CYP3A4, an enzyme of the cytochrome P450 system, which metabolizes atorvastatin to its main metabolites. The objective of this study was to evaluate the response of cholesterol and triglycerides to atorvastatin according to vitamin D levels. Sixty-three patients with acute myocardial infarction treated with low and high doses of atorvastatin were included. Levels of total cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol were measured at baseline and at 12 months of follow-up. Baseline levels of 25-hydroxyvitamin D (25-OHD) were classified as deficient (<30 nmol/L), insufficient (30–50 nmol/L), and normal (>50 nmol/L). In patients with 25-OHD <30 nmol/L, there were no significant changes in levels of total cholesterol (173±47 mg/dL versus 164±51 mg/dL), triglycerides (151±49 mg/dL versus 177±94 mg/dL), and LDL cholesterol (111±48 mg/dL versus 92 45± mg/dL); whereas patients with insufficient (30–50 nmol/L) and normal vitamin D (>50 nmol/L) had a good response to atorvastatin. We suggest that vitamin D concentrations >30 nmol/L may be required for atorvastatin to reduce lipid levels in patients with acute myocardial infarction.http://dx.doi.org/10.1155/2010/320721
spellingShingle José Luis Pérez-Castrillón
Laura Abad Manteca
Gemma Vega
Javier del Pino Montes
Daniel de Luis
Antonio Dueňas Laita
Vitamin D Levels and Lipid Response to Atorvastatin
International Journal of Endocrinology
title Vitamin D Levels and Lipid Response to Atorvastatin
title_full Vitamin D Levels and Lipid Response to Atorvastatin
title_fullStr Vitamin D Levels and Lipid Response to Atorvastatin
title_full_unstemmed Vitamin D Levels and Lipid Response to Atorvastatin
title_short Vitamin D Levels and Lipid Response to Atorvastatin
title_sort vitamin d levels and lipid response to atorvastatin
url http://dx.doi.org/10.1155/2010/320721
work_keys_str_mv AT joseluisperezcastrillon vitamindlevelsandlipidresponsetoatorvastatin
AT lauraabadmanteca vitamindlevelsandlipidresponsetoatorvastatin
AT gemmavega vitamindlevelsandlipidresponsetoatorvastatin
AT javierdelpinomontes vitamindlevelsandlipidresponsetoatorvastatin
AT danieldeluis vitamindlevelsandlipidresponsetoatorvastatin
AT antonioduenaslaita vitamindlevelsandlipidresponsetoatorvastatin